Technology Listings


Mark Goodman

Mark Goodman is a professor in the Department of Radiology and the director of the Radiopharmaceutical Discovery Lab. His research centers on the radiotracer development of positron emission tomography(PET) and single photon emission computed tomography(SPECT). Additionally, his research helps the development of a commercialized radiotracer, methylbranched fatty acid [123I] BMIPP (Cardiodine), in Japan.

 

https://winshipcancer.emory.edu/bios/faculty/goodman-mark-m.html

TECHNOLOGIES
PET Imaging Agents for the Diagnosis of Prostate and Other Cancers
CRF-1 Receptor Antagonists for PET Imaging or as Potential Therapeutics
Amino Acid-Derived Radiotracer Compounds for PET Cancer Imaging
SECTORS
CATEGORIES
Diagnostics
Drug Discovery
FakeName
Medical
Medical Device
Micro and Nanotechnology
Non-Therapeutics
Research Tools
Software
Therapeutics
Vaccines